Pages that link to "Q47822814"
Jump to navigation
Jump to search
The following pages link to Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. (Q47822814):
Displaying 50 items.
- Concerning RNA-guided gene drives for the alteration of wild populations (Q21128771) (← links)
- A CRISPR CASe for high-throughput silencing (Q21131235) (← links)
- CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems (Q21558788) (← links)
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes (Q22337358) (← links)
- Cas9 as a versatile tool for engineering biology (Q24564294) (← links)
- Defects of the Glycinergic Synapse in Zebrafish (Q26738425) (← links)
- Methods of Genome Engineering: a New Era of Molecular Biology (Q26741958) (← links)
- Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease (Q26742136) (← links)
- Genome Engineering with TALE and CRISPR Systems in Neuroscience (Q26752488) (← links)
- Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future (Q26753206) (← links)
- Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases (Q26778992) (← links)
- Genome-editing tools for stem cell biology (Q26800186) (← links)
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering (Q26859390) (← links)
- Visualizing epigenetics: current advances and advantages in HDAC PET imaging techniques (Q26862755) (← links)
- A CRISPR method for genome engineering (Q27000786) (← links)
- Exciting prospects for precise engineering of Caenorhabditis elegans genomes with CRISPR/Cas9 (Q27008421) (← links)
- Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy (Q27335054) (← links)
- Simple Genome Editing of Rodent Intact Embryos by Electroporation (Q27343688) (← links)
- CRISPR-Cas9: from Genome Editing to Cancer Research (Q28066263) (← links)
- Rheumatoid arthritis: identifying and characterising polymorphisms using rat models (Q28073099) (← links)
- Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity (Q28075883) (← links)
- CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells (Q28076522) (← links)
- The application of genome editing in studying hearing loss (Q28081706) (← links)
- The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases (Q28085767) (← links)
- Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos (Q28245450) (← links)
- CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections (Q28552274) (← links)
- A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation (Q28552981) (← links)
- CRISPR-Cas systems for editing, regulating and targeting genomes (Q29615781) (← links)
- A CRISPR toolbox to study virus-host interactions (Q29994612) (← links)
- Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome. (Q30367333) (← links)
- Generation of Esr1-knockout rats using zinc finger nuclease-mediated genome editing (Q30405476) (← links)
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins (Q33657682) (← links)
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. (Q33657689) (← links)
- Gene targeting using the Agrobacterium tumefaciens-mediated CRISPR-Cas system in rice (Q33737664) (← links)
- Translational Rodent Models for Research on Parasitic Protozoa-A Review of Confounders and Possibilities (Q33770491) (← links)
- Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells (Q33791002) (← links)
- CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences (Q33791286) (← links)
- Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform (Q33851650) (← links)
- Generation of muscular dystrophy model rats with a CRISPR/Cas system (Q33868949) (← links)
- Highly efficient targeted mutagenesis in one-cell mouse embryos mediated by the TALEN and CRISPR/Cas systems (Q33907052) (← links)
- Mouse models for studying the formation and propagation of prions (Q33931079) (← links)
- A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice (Q33985544) (← links)
- Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases. (Q33994867) (← links)
- The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs (Q34043553) (← links)
- CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages. (Q34044420) (← links)
- Conditional targeting of Ispd using paired Cas9 nickase and a single DNA template in mice (Q34076889) (← links)
- Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat. (Q34144270) (← links)
- Methods for targeted mutagenesis in zebrafish using TALENs (Q34150507) (← links)
- Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes (Q34200242) (← links)
- An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 system (Q34208869) (← links)